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during a mean observation period of 25 months (from 8 to 36 
months!. Two patients irreversibly rejecwd their grafts during 
c-yclosporine treatment (patients S.G. and Z.F.). In one of tlfese 
patients. cycJosporine treatment wa!' withdrawn at six weeks 
after transplantation because of thromboembolic occlusion of 
the femoral artery. 
In this patient acute rejection occurred on day i after discon· 
tinuation of systemic immunosuppression. One patient experi-
enced one reversible acute rejection episode during cyclosporine 
treatment. and another irreversible episode 21 months after 
discontinuation of cycJosporine treatment (patient H.U.). One 
patient experienced an acute rejection episode during. and 
another episode after. discontinuation of cyclosporine treat-
ment (patient F_O.). Both these rejection episodes rapidly re-
sponded to treatment with i.v. methylprednisolone. Side effects 
related to systemic immunosuppression with cycJosporine at 
this low-dose level were minimal (Table 1). In particular. none 
of the patients experienced renal dysfunction. which otherwise 
represents the main complication of cyclosporine therapy. The 
only toxicity observed was development of transient hyperten-
sion in three and aggravation of preexisting hypertension in 
one further patient. These side-effects were equally distributed 
between patients initially receiving a fll'St i.v. infusion of cyclo-
sporine and those who were started on oral medication. 
After cessation of systemic prophylactic immunosuppression. 
13 patients had functioning grafts and were followed for 5-33 
months (mean follow-up 22.1 months). During this time grafts 
remained quiescent in eleven patients. Acute rejection episodes 
occWTed in two patients who had already rejected their graft 
during prophylactic immunosuppression with cyclosporine (pa-
tients H.U. and F.O. [Table 1». No systemic symptoms or 
precipitating local infections occurred in any of the rejection 
ep~es. 
The remaining patient CH.U. [Table 1]) lost the graft 21 
months after withdrawal of cyclosporine despite systemic and 
topical administration of corticosteroids. 
The efficacy and toxicity of short-term immunosuppression 
with cyclosporine was tested in fifteen high-risk cornea allo-
graft recipients. Strong vascularization represented the main 
risk factor in these cases. Systemic immunosuppression con-
sisted of a three-month course of 5 mg/kg p.o. of cyclosporine 
per day and was supplemenwd by topical application of corti-
costeroids. Of the 15 patients. 12 enjoyed an uncomplicated 
course and functional restoration during an average period of 
observation of more than two years. Graft rejection episodes 
were rare during, and after cessation of systemic immuno-
suppression four patients experienced a total of six rejection 
episodes. and only three grafts were lost. Toxic side effects of 
the three-month treatment with low-dose cyclosporine were 
minimal and mainly related to transient hypertension in three 
and agp8\'ation of~ preexist in/: hypertension in one further 
patient. We thus conclude thaI low-dost' cyclosporine af, short· 
term immunosuppression has an acceptable toxicity and if' 
effective in preventing rejt>ction in high· risk corneal allograft 
recipients. 
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TRA1':SMISSION OF FATAL HERPES SIMPLEXI1':FECTION THROUGH RENAL TRANSPLANTATION ' 
Herpes simplex virus (HSV)· infections cause significant 
morbidity and occasional mortality following organ transplan-
I Thil' work ""85 supported by Research GraDta from the Veterans 
Administration. and by Project Grant AM·29961 from the National 
Institutes of Health. Betheada, MD 
• Abb~viationl used: AUT alanine aminotransferue; ASAT 81· 
part.8u aminotrans{erue; CIA cyclosporine: DNA deoxyribonucleic 
aCid. HSV herpes simplex virus; PO postoperative. 
tation. The majority of these infections are belie\'ed to be 
reactivation of 8 latent and remote infection in the recipient 
(1-3). Rare cases of primary herpes simplex infection following 
renal transplantation have been reportt-d but the source of 
infection in these is unknown (4.5). 
Donor kidneys have been shown to be a source of cytome~­
alovirus infections (2) but evidence ha~ been minimal regarding 
their role in HSV infections (6.7). WI.' recently documented 
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one instance of transmission of primary HS\··2 infe<"tion by 
~nal transplantation but thou~ht thi~ wa~ 8 rart' occurrence 
(7). but 21 months after that wt' had a tfa~r ex~rience in 
which two renal recipipntl' dipd of disseminated ht'rpt's infpc-
tion with fulminant hepatitis after receiving organs from the 
same donor. Liver and heart from that donor wefe also trans-
planted into different recipients. It is our intent in this report 
to present evidence that donor kidneys in this case also acted 
as a source of the herpes simplex infection. 
Renal recipient !Vo. 1. A 21· year-old man received a cadaveric 
kidney transplant on June 19. 1986 from the same donor as 
recipient No.2. Immunosuppression was with CsA and steroids. 
On the 7th postoperaa..e (PO) day monoclonal antibody OKT3 
(Ortho Pharmaceutical Company. Raritan. NJ) therapy was 
added for suspected rejection. The patient became febrile from 
the 10th PO day. with no jentified source. On the 14th PO 
day his hepatic transaminaM's were elevated (ASAT 1075 U/L. 
ALAT 1181 U/U. Two days after this he developed severe 
coagulopathy and gastrointestinal bll'f'ding. OKT3 therapy was 
stopped and i.v. acyclovir was start~ because of isolation of 
HSV from the other renal recipient's blood. No mucosal or skin 
lesions suggestive of herpes infection were present. Over the 
nen several hours. however. his coagulopathy worsened and he 
died of hyperkalemic cardiac arrest in spite of hemodialysis. 
An autopsy was denied. 
Renal recipient No.2. A 30-year-old man received a cadaveric 
kidney transplant on June 19 ~ 986. Immunosuppression was 
with cyclosporine and steroid ie became febrile on the 10th 
PO day. This was thought to tx Ie to rejection and was treated 
with bolus steroids. On the 11th PO day his hepatic transami-
nases were ASAT 824 U/L and ALAT 1135 U/L. At that time 
he was started on Lv_ ampicillin because of a positive blood 
culture for enterococcus. He developed severe back pain, right-
sided abdominal pain, and tenderness from the 14th PO day 
OD. tntrasound of gallbladder and biliary scintiscan were un-
remarkable. Over the nen few days he continued to be febrile, 
developed coagulopathy and gastrointestinal bleeding, and re-
quired ventilatory support. The true nature of the problem was 
suspected when a buffy coat culture drawn on the 14th PO day 
yielded berpes simplex virus, and i.v. acyclovir was begun. No 
skin or mucosal lesions suggestive of herpes infection were 
evident. His clinical condition deteriorated with hypoglycemia. 
hypoxemia, and seizures. and he died on the 19th PO day. 
Postmortem examination revealed hepatomegaly (2880 g) 
with extensive hemorrhagic hepatic necrosis. In adclition. mas-
sive gastrointestinal hemorrhage with multiple petechial hem-
orrhages into skin, mucous membranes, heart. and brain. were 
present with recent right cerebellar and left superior frontal 
infarcts. 
Microscopically, tbe liver showed extensive coagulative ne-
crosis. The sparse remaining viable liver parenchyma showed 
well-demarcated areas of necrosis with no particular distribu-
tion with respect to the lobular architecture. The necrotic tissue 
,,'as infiltrated with neutrophils and contained cellular and 
nuclear debris (Fig. 1). Although viral inclusions were scarce. 
Beveral foci of multinucleate hepatocytes that contained large 
intranuclear Cowdr)' type A inclusion!\ were seen (Fig. 1A)' 
lmmunoperoxidase staining of the liver for herpes simplex virus 
type 2 was strongly positive. Transmission electron microscopy 
revealed clusters of viral particles with features characteristic 
of the herpes family (Fig. IB). Remarkably, the brain and other 
organs were free of apparent viral infection. 
FIGURE 1. Microscopic aection of liver. showing extensive hemor-
rhagic necrosis (H&E; x2001. Intranuclear inclusions typical of herpes 
simplex were recognized in the SPS!'1Ie remaining viable parenchyma 
(insert lAo H&E; 500x) at the edge of necrotic ~~ Electron micro-
graphs revealed viral particles characteristic of tbt herpes lIimplex 
group (insert lB. uranyl acetate and lead citrate. 46.100x). 
The cause of death in this patient was determined to be 
secondary to HSV induced massive hepatic necrosis resulting 
in coagulopathy, diffuse hemorrhage, and hypotension, 
Liver recipient. A 36-year-old man with primary sclerosing 
cholangitis received an orthotopic liver transplant on June 6. 
1986. His postoperative course was complicated by hepatic 
artery thrombosis and enterobacter septicemia. He was retrans-
planted on June 18, 1986. Four days after this. he developed 
tongue and pharyngeal ulcerations from which HSV type 1 was 
eventually grown. He was started on i.v. acyclovir and these 
lesions gradually resolved. This patient had 2 liver biopsies on 
the 8th and 18th PO days after the second liver transplant_ 
Both showed no evidence of herpes hepatitis. His first hepatic 
allograft, after removal, clid not show evidence of herpes sim-
plex infection. Eventually he was discharged from hospital and 
is currently doing welL 
Heart recipient. A 17 -year-old boy received an orthotopic 
heart transplant on June 17, 1986 and required retransplanta-
tion on June 18. 1986. He clied 3 days following his second 
transplant of severe cardiovascular instability. No skin or mu-
cosallesions were evident_ Autopsy clid not reveal any histolog-
ical evidence of HSV infection. 
Dorwr. The two kidneys. the second liver. and the second 
heart in the above transplant procedures were all obtained from 
the same donor. He was a 26-year-old male victim of an 
automobile collision with a closed head injury and crush injury 
to left lower enremity. He was treated in hospital for 3 days 
with several blood transfusions. Any history of previous herpes 
infection was unknown. Clinical examination at admission djd 
not reveal evidence of oral. cutaneous. or genital sores. 
Viral studies. Urine specimens. throat swabs. and buffy coau 
were inoculated onto monolayer cultures of human foreskin 
fibroblasts and also onto rabbit kidney cells. Presumptive iden-
tification of HSV was made by characuristic cytopathology 
appearing in both human and rabbit ceilE-. The isolates were 
confirmed as HSV and typed with monoclonal antibodies (Syva. 
Genetic Systems Corp .. Seattle. WA) using direct immunoflu-
orescence (Table 1). Sera from the donor. both renal recipients 
and the liver recipient. were available and were assayed for the 
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TABLE \. Re,ul~ or "irologica! cu!lul'u in livt'r and lucint'y rKiplt'nt.l 
Throallweb Bully coal bklOd 
lUna! Tt'Cipient !\Io. 1 
Renal I'Klpit'nt !\Io. 2 
Liver rKipient 
HSV II Il6th day) 
HSV II';'th day) 
HSV II 11~th day) 
HS\' II 114th day) 
HSV II (16th day) Not dont' 
HSV U lautopsy) 
presence of neutralizing antibodies to HSV-l and HSV-2 (8); 
the results are as shown In Table 2. 
Viral DNA isolatWI1. Five viral isolates were available for 
analysis. These consisted of isolates from urine and buffy coat 
specimens from renal recipient No.1. liver and throat swab 
from renal recipient No.2, and a tongue isolate from the liver 
re<:ipient. All isolates from the renal re<:ipients were character-
ized as HSV·2 by monoclonal antibody fluorescence staining. 
The tongue specimen (liver recipient) was identified as HSV-
1. The 4 HSV -2 isolates were examined for type and intratype 
nucleotide sequence variation by restriction endonuclease 
analysis. Standard HSV·l (strain F) and HSV-2 (strain G) 
were included for comparison. In the electropherograms shown 
in Figure 2, a and b the strains are denoted by patient (lor 2). 
source of isolate (urine [UR). buffy coat (BC), tbroat swab 
(TS] and liver (LV)) and clinical isolate number. Arrows indi-
cate the presence or absence of specific fragments tbat distin· 
guish strains. Arrows 1 and 3 of Fig. 2a denote differences 
between patients' strains and HSV·2; arrows 2 and 4, between 
patients' strains and HSV·1. In Figure 2b, arrows refer to 
restriction fragments that differentiate patient DNAs from 
standard HSV·2 (strain G). The apparent differences between 
the patterns in the region to the left of arrow 1 in Fig. 2b were 
not consistently seen and are apparently due to incomplete 
restriction. Restriction endonuclease proftles clearly dermed all 
isolates aa HSV ·2. Isolates from patients Nos. 1 and 2 revealed 
similar cleavage patterns. While minor heterogeneities in diges-
tion patterns were observed between the 2 patients, similar 
differences were also noted between isolates from a single 
individual. Herpes simplu-2 DNA isolated from unrelated 
patients waa also analyzed by the same methods (data not 
shown). The restriction patterns showed a variety of distinctly 
different proftles. 
A large number of patients show serological evidence of paat 
HSV infection M the time of renal transplantation (1-.3), and 
the great majority of HSV infections occurring after transplan· 
tation are -believed to be reactivation of these past infections 
(2)_ Both of our renal re<:ipients had no prior history of herpetic 
lesions and their pretransplant sera did not have neutralizing 
antibodies to HSV·l or ·2. This is strong evidence that these 
infections were primary; however, the liver recipient had a high 
titer of neutralizing antibodies to both subtypes before his first 
transplant and thus waa at risk for reactivation_ 
Both renal recipients had identical incubation periods and 
similar clinical courses, and both died of fulminant hepatitis. 
In one of them autopsy showed maasive necrosis of the liver 
with characteristic inclusion bodies. and herpesvirus particles 
were seen on electron microscopy. HSV·2 was isolated from 
buffy coat cultures taken before death. The DNA restriction 
endonuclease patterns of the viral isolates from both are very 
similar except for minor variations. These provide evidence 
that the virus strains in these patients had a common source. 
Surgical teams (or both patients were different, and patients 
had minimal contact with each other on the ward Neither of 
the renal recipients received blood at operation. Thus, evidence 
TABLE 2. Serum neutrali.unll antibod~ titers to HS\' I and HSV II 
R~n.1 rf'<:;ill~nt ~nal N'Clplrnt t..'·~r r ... ·lpltnt Donor 
Date So. 1 !'u. Z 
HSV I HSV II HS\' I HSV II HS\' I HS\' II HSV I HSV II 
6/6/86 >256 >256 
6/18/86 <4 <4 <4 <4 >256 4 
6126/86 <4 <4 <4 <4 
7/3/86 <4 <4 :S4 <4 
Hind 11 
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FIGURE 2. (a and b) Restriction endonucleue promH of DNA from 
standard HSV strai.M and isolates from 2 kidney transplant recipienu. 
The laboratory strama are HSV-l (strain F) and HSV-2 (strain G); the 
clinical isolates are denoted by patient (1 or 2). site or isolation (urine 
(URI, buffy coat [BCI, throat swab [TS), and liver (LV}) and specimen 
number. The restriction endonucleues uaed are listed abovt' ea~h geL 
The arrows refer to restriction fragmeou that differentiate patienu' 
DNA from standard straina. 
is strong implicating the donor kidneys as tbe common source 
of infection for both our renal re<:ipients_ 
Donor organs have not been considerE:d as a potential route 
of transmission of HSV. There is a ree.nt report presenting 
evidence tbat donor kidneys could act aa a vehicle for trans· 
mission of HSV (7). HSV normally enters the body through 
abraded skin or mucosal surfaces. The virus is known to estab-
lish latency in ganglionic neurons after primary infection (9, 
10). FollOwing genital HSV infection, it is possible tbat the 
virus could reach the ureter and kidney along rich periureteric 
and perinephric autonomic nerve plexuses and remain latent 
there_ Other possible routes to the kidney would be viremia 
during a primary HSV infection (11), or via an ascending route 
from the external genitalia in a catheterized patient. Although 
one report discusses the isolation of HSV from 5 of 10 normal 
kidneys (6), the author did not actually isolate the virus in 
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tiuue culture. and other investigators have not been ablt' to 
confirm their results. Thus it remain!; unclear whether HS\' 
can establish lau-ncy in thE' kidney. It is interesting that WE' did 
not isolate HSV or find histological evidence of HSV in thl' 
one donor kidney exsmint'd at autopsy, However. it is well 
known that the kidneys may transmit cytomegalovirus infec-
tion without overt evidence of infection in the kidney (J 2), It 
is interesting that the donor had a low titer of neutralizing 
antibodies to HSV -2. This might indicate that the infection 
was recently acquired. Although no mucocutaneous herpetic 
lesions were evident, they might have been missed in a poly-
trauma victim. The fact that the liver recipient did not develop 
HSV -2 infection may t1,!sult from anyone of the following: 
acyclovir therapy 8ta~ fortuitously for his tongue lesions, 
which eventually grew HSV-l; his high titer of neutralizing 
antibodies to HSV -2; and inability of herpes simplex to estab-
lish latency in liver tissue, and bence not be transmissible 
through transplantation. 
This is the second documented instance of transmission of 
HSV infection by renal transplantation at our institution in 2 
years. Unlike the first case. these cases had a fulminant course 
and a fatal outcome. Identification of these cases was more 
difficult because of the absence of skin and mucosal lesions. 
Whether transmission of HSV can happen through a liver or 
heart transplant is not known at present, but with efficient 
utilization of organs from a single donor becoming more com-
mon, this type of transmission could have a devastating effect 
on several recipients. HSV should be considered as a possible 
pathogen whenever fulminant hepatitis occurs in a transplant 
recipient. Knowledge of donor and recipient serological status 
for HSV may be helpful in identifying transplant recipients at 
risk for such infections and prophylactic acyclovir therapy 
• bould strongly be considered whenever a kidney is trans-
planted from a seropositive donor to a seronegative recipient. 
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THE EFFECT OF CYCLOSPORINE ON THE PHARMACOKINETICS OF PREDNISOLONE IN RENAL 
TRANSPLANT PATIENTS 
Immunosuppressive drugs have an important role in the 
prevention of graft rejection following renal transplantation. 
Traditionally, immunosuppressive therapy consisted of the ad-
ministration of azathioprine and corticosteroids (J). The intro-
duction of cyclosporine has greatly improved graft survival for 
cadaver transplants (2-4). Cyclosporine is now widely used as 
immunosuppressive therapy in renal transplantation in com-
bination with corticosteroids. 
Some investigators have suggested that cyclosporine inhibits 
the elimination of prednisolone when both drugs are adminill-
tered concurrently (5,6). Possible mechanismfs) for this inter-
action include; (l) cyclosporine-induced reduction in tbe 
amount of hepatic cytochrome P 460, (2) cyclosponne-induced 
hepatotoxicity, and (3) competition between cyclosporine and 
predinisolone for bepatic drug metabolizing enzymes (5). 
Previously published studies that evaluated tbe cyclosporine-
prednisolone int.eraction did Dot evaluate changes in the phar-
macokinetics of free prednisolone. This latter variable maybe 
particularly important since prednisolone plasma binding is 
nonlinear and may be affected by renal disease. 
The purpose of the present study was to evaluate the effect 
of cyclosporine on the pharmacokinetics of free and total pred-
nisolone following its intravenous administration to renal 
transplant patients. 
The effect of cyclosporine on prednisolone pharmacokinetics 
was evaluated in six patients (5 female), ranging in age from 
